Sensus Healthcare (SRTS) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for May 27, 2025, with proxy materials distributed to shareholders of record as of April 10, 2025.

• Key items include director election, amendment of the 2017 Incentive Plan, advisory vote on executive compensation, and auditor ratification.

• The 2024 Annual Report and audited financials accompany the proxy statement.

Voting matters and shareholder proposals

• Shareholders will vote on electing one Class I director for a three-year term, amending the 2017 Incentive Plan, approving executive compensation (say-on-pay), and ratifying the appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP as the independent auditor for 2025.

• The board recommends voting in favor of all proposals.

• Shareholders may submit proposals for the 2026 meeting by January 2, 2026, and director nominations between January 27 and February 26, 2026.

Board of directors and corporate governance

• The board consists of five members, with a classified structure (three classes, staggered terms).

• Three directors are independent per Nasdaq standards; two are not, including the CEO and President.

• Board committees include Audit, Compensation, and Corporate Governance/Nominating, all with written charters and independent membership.

• The board held twelve meetings in 2024; all but one director attended at least 75% of meetings.

• Stockholders can communicate with the board via the corporate secretary.